Global Age-Related Macular Degeneration (AMD) Market Size To Grow At A CAGR Of 8.93% In The Forecast Period Of 2022-2027
The ‘Global Age-related macular degeneration (AMD) market Size, Share, Growth, Analysis, Report and Forecast 2022-2027’ by Expert Market Research gives an extensive outlook of the global age-related macular degeneration (AMD) market, assessing the market on the basis of its segments like products, drugs, route of administration, and major regions.
The report studies the latest updates in the market, along with their impact across the market. It also analysis the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter’s Five Forces Models.
Age-Related Macular Degeneration (AMD) Market Share, Size, Trends, Industry Report, Key Player, Major Segments, and Forecast
The key highlights of the report include:
Market Overview (2017-2027)
- Forecast CAGR (2022-2027): 8.93%
|Market Size in 2020||USD 1.58 billion|
|Revenue Forecast in 2026||USD 2.64 billion|
|Growth Rate CAGR||8.93%|
|Major Players||Bayer AG, F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), and Others.|
The global age-related macular degeneration (AMD) market is expected to register growth during the forecast period on account of the surging older age population across the globe. The rising age-related eye diseases coupled with advancements in technology are expected to fuel the market of age-related macular degeneration. The growing awareness among consumers regarding the treatment options for the condition are expected to support the growth of the age-related macular degeneration (AMD) market over the forecast period.
Get a Free Sample Report with Table of [email protected] https://www.expertmarketresearch.com/reports/age-related-macular-degeneration-market/requestsample
The growing research and development activities regarding eye disease diagnostics and treatment are anticipated to propel the market growth over the upcoming years across the globe. Moreover, the rising disposable income among consumers along with the increasing popularity of age-related macular degeneration treatment is likely to fuel the growth of the market. With government initiatives such as the United States FDA approval of Faricimab, a drug for treating age-related macular degeneration, the market is likely to propel in the coming year.
Age-related macular degeneration (AMD) Industry Definition and Major Segments
Age-related macular degeneration is an eye condition in which the individual central vision gets blurred. It occurs when aging impacts the macula which is a part of the retina. It is the part of the eye that maintains sharp and straight-ahead vision.
Read Full Report with Table of [email protected] https://www.expertmarketresearch.com/reports/age-related-macular-degeneration-market
Based on product, the market is segmented into:
- Wet AMD
- Dry AMD
By drug, the market is classified into:
Based on the route of administration, the market is segmented into:
On the basis of region, the market is divided into:
- North America
- Latin America
- Asia Pacific
- Middle East and Africa
Age-Related Macular Degeneration (AMD) Market Trends
Geographically, the North American region is anticipated to gain momentum over the coming years in the age-related macular degeneration (AMD) market on account of the growing prevalence of age-related macular degeneration.
The growing geriatric population coupled with the well-established healthcare industry and increasing facilities for patients is aiding the market growth of age-related macular degeneration across the region. Moreover, the surging developments in treatments for age-related macular degeneration are driving the market growth of age-related macular degeneration across the North American region.
Meanwhile, the Asia Pacific region is anticipated to witness age-related macular degeneration (AMD) market growth due to the growing aging population in the region and evolving healthcare facilities. With favorable government initiatives to encourage the affordability of costly anti-VEGF products, market growth of age-related macular degeneration is likely to enhance over the forecast period across the region. Rapid urbanization and rising awareness regarding the treatment for age-related macular degeneration among people are likely to push forward the market growth of age-related macular degeneration in the region.
Key Market Players
The major players in the global age-related macular degeneration (AMD) market report are :
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- Regeneron Pharmaceuticals Inc.
The report covers the market shares, capacities, plant turnarounds, expansions, investments, and mergers and acquisitions, among other latest developments of these market players.
Read More Reports :
Angiography Devices Market: https://www.expertmarketresearch.com/reports/angiography-devices-market
Polybutylene Adipate Terephthalate (PBAT) Market: https://www.expertmarketresearch.com/reports/polybutylene-adipate-terephthalate-pbat-market
3D Cell Culture Market: https://www.expertmarketresearch.com/reports/3d-cell-culture-market
Collagen Market: https://www.expertmarketresearch.com/reports/collagen-market
Alkyl Polyglucosides (APG) Biosurfactants Market: https://www.expertmarketresearch.com/reports/alkyl-polyglucosides-apg-biosurfactants-market
About Us :
Expert Market Research (EMR) is a leading market research company with clients across the globe. Through comprehensive data collection and skillful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium-scale enterprises.
EMR customizes syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective, and intelligent business strategies and ensure their leadership in the market.
Media Contact :
Company Name: Claight Corporation
Contact Person: Louis Wane, Corporate Sales Specialist – U.S.A.
Email: [email protected]
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gloud Street, Sheridan, WY 82801, USA